The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. / Goodman, Anna L; Forbes, Emily K; Williams, Andrew Richard; Douglas, Alexander D; de Cassan, Simone C; Bauza, Karolis; Biswas, Sumi; Dicks, Matthew D J; Llewellyn, David; Moore, Anne C; Janse, Chris J; Franke-Fayard, Blandine M; Gilbert, Sarah C; Hill, Adrian V S; Pleass, Richard J; Draper, Simon J.

In: Scientific Reports, Vol. 3, 23.04.2013, p. 1706.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Goodman, AL, Forbes, EK, Williams, AR, Douglas, AD, de Cassan, SC, Bauza, K, Biswas, S, Dicks, MDJ, Llewellyn, D, Moore, AC, Janse, CJ, Franke-Fayard, BM, Gilbert, SC, Hill, AVS, Pleass, RJ & Draper, SJ 2013, 'The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment', Scientific Reports, vol. 3, pp. 1706. https://doi.org/10.1038/srep01706

APA

Goodman, A. L., Forbes, E. K., Williams, A. R., Douglas, A. D., de Cassan, S. C., Bauza, K., Biswas, S., Dicks, M. D. J., Llewellyn, D., Moore, A. C., Janse, C. J., Franke-Fayard, B. M., Gilbert, S. C., Hill, A. V. S., Pleass, R. J., & Draper, S. J. (2013). The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. Scientific Reports, 3, 1706. https://doi.org/10.1038/srep01706

Vancouver

Goodman AL, Forbes EK, Williams AR, Douglas AD, de Cassan SC, Bauza K et al. The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. Scientific Reports. 2013 Apr 23;3:1706. https://doi.org/10.1038/srep01706

Author

Goodman, Anna L ; Forbes, Emily K ; Williams, Andrew Richard ; Douglas, Alexander D ; de Cassan, Simone C ; Bauza, Karolis ; Biswas, Sumi ; Dicks, Matthew D J ; Llewellyn, David ; Moore, Anne C ; Janse, Chris J ; Franke-Fayard, Blandine M ; Gilbert, Sarah C ; Hill, Adrian V S ; Pleass, Richard J ; Draper, Simon J. / The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. In: Scientific Reports. 2013 ; Vol. 3. pp. 1706.

Bibtex

@article{8f6237c419fe46548630a546a3774cb5,
title = "The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment",
abstract = "Rodent malaria species Plasmodium yoelii and P. chabaudi have been widely used to validate vaccine approaches targeting blood-stage merozoite antigens. However, increasing data suggest the P. berghei rodent malaria may be able to circumvent vaccine-induced anti-merozoite responses. Here we confirm a failure to protect against P. berghei, despite successful antibody induction against leading merozoite antigens using protein-in-adjuvant or viral vectored vaccine delivery. No subunit vaccine approach showed efficacy in mice following immunization and challenge with the wild-type P. berghei strains ANKA or NK65, or against a chimeric parasite line encoding a merozoite antigen from P. falciparum. Protection was not improved in knockout mice lacking the inhibitory Fc receptor CD32b, nor against a ¿smac P. berghei parasite line with a non-sequestering phenotype. An improved understanding of the mechanisms responsible for protection, or failure of protection, against P. berghei merozoites could guide the development of an efficacious vaccine against P. falciparum.",
author = "Goodman, {Anna L} and Forbes, {Emily K} and Williams, {Andrew Richard} and Douglas, {Alexander D} and {de Cassan}, {Simone C} and Karolis Bauza and Sumi Biswas and Dicks, {Matthew D J} and David Llewellyn and Moore, {Anne C} and Janse, {Chris J} and Franke-Fayard, {Blandine M} and Gilbert, {Sarah C} and Hill, {Adrian V S} and Pleass, {Richard J} and Draper, {Simon J}",
year = "2013",
month = apr,
day = "23",
doi = "10.1038/srep01706",
language = "English",
volume = "3",
pages = "1706",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment

AU - Goodman, Anna L

AU - Forbes, Emily K

AU - Williams, Andrew Richard

AU - Douglas, Alexander D

AU - de Cassan, Simone C

AU - Bauza, Karolis

AU - Biswas, Sumi

AU - Dicks, Matthew D J

AU - Llewellyn, David

AU - Moore, Anne C

AU - Janse, Chris J

AU - Franke-Fayard, Blandine M

AU - Gilbert, Sarah C

AU - Hill, Adrian V S

AU - Pleass, Richard J

AU - Draper, Simon J

PY - 2013/4/23

Y1 - 2013/4/23

N2 - Rodent malaria species Plasmodium yoelii and P. chabaudi have been widely used to validate vaccine approaches targeting blood-stage merozoite antigens. However, increasing data suggest the P. berghei rodent malaria may be able to circumvent vaccine-induced anti-merozoite responses. Here we confirm a failure to protect against P. berghei, despite successful antibody induction against leading merozoite antigens using protein-in-adjuvant or viral vectored vaccine delivery. No subunit vaccine approach showed efficacy in mice following immunization and challenge with the wild-type P. berghei strains ANKA or NK65, or against a chimeric parasite line encoding a merozoite antigen from P. falciparum. Protection was not improved in knockout mice lacking the inhibitory Fc receptor CD32b, nor against a ¿smac P. berghei parasite line with a non-sequestering phenotype. An improved understanding of the mechanisms responsible for protection, or failure of protection, against P. berghei merozoites could guide the development of an efficacious vaccine against P. falciparum.

AB - Rodent malaria species Plasmodium yoelii and P. chabaudi have been widely used to validate vaccine approaches targeting blood-stage merozoite antigens. However, increasing data suggest the P. berghei rodent malaria may be able to circumvent vaccine-induced anti-merozoite responses. Here we confirm a failure to protect against P. berghei, despite successful antibody induction against leading merozoite antigens using protein-in-adjuvant or viral vectored vaccine delivery. No subunit vaccine approach showed efficacy in mice following immunization and challenge with the wild-type P. berghei strains ANKA or NK65, or against a chimeric parasite line encoding a merozoite antigen from P. falciparum. Protection was not improved in knockout mice lacking the inhibitory Fc receptor CD32b, nor against a ¿smac P. berghei parasite line with a non-sequestering phenotype. An improved understanding of the mechanisms responsible for protection, or failure of protection, against P. berghei merozoites could guide the development of an efficacious vaccine against P. falciparum.

U2 - 10.1038/srep01706

DO - 10.1038/srep01706

M3 - Journal article

C2 - 23609325

VL - 3

SP - 1706

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

ER -

ID: 45492249